SGI Annual Scientific Meeting — March 21-24, 2012
Early-bird Registration Deadline: Feb. 17, 2012
Provisional Program Details
2012 SGI Meeting Registration Form
2012 SGI Meeting at a Glance
Record Number of Abstracts Submitted
The deadline for submission of abstracts for the 2012 SGI Annual Scientific Meeting has past and the final count of submitted abstracts was 1,159, which represents a record high for the SGI. We are now in the process of collating the abstracts and sending them for peer review. Many thanks to all of you who submitted abstracts or who supported the submission of abstracts. The high number of abstracts suggests that we will have an excellent attendance in San Diego, so please remember to register sooner than later to ensure you are able to reserve a hotel room at the SGI discounted rate.
SAVE THE DATE
Society for Gynecologic Investigation Summit 2012
Prematurity and Stillbirth
Antecedents, Mechanisms and Sequelae
Aug. 3-5, 2012
Brisbane Convention & Exhibit Centre
Professor John Challis: University professor emeritus, University of Toronto; adjunct professor, University of Western Australia; past president SGI.
Professor Sir Peter Gluckman: Chief science advisor to the prime minister of New Zealand.
Professor Stephen Lye: Vice-chair, research and professor of obstetrics and gynecology at the University of Toronto; co-chair of the Centre for Women's and Infant's Health at Mount Sinai Hospital, Toronto; president, SGI.
Professor John Mattick: Executive director, Garvan Institute.
Professor Leslie Myatt: Professor of obstetrics and gynecology, co-director Center for Pregnancy and Newborn Research, University of Texas Health Science Center, San Antonio; past president, SGI.
Endometrial emerges as most common in women's reproductive cancers
The most common form of cancer of the female reproductive tract in the United States is endometrial carcinoma — cancer of the lining of the uterus, or endometrium. Endometrial cancer accounts for more than 95 percent of uterine cancers, which themselves represented approximately 6 percent of all cancers diagnosed among U.S. women in 2010. It is estimated that 46,470 women will be diagnosed with uterine cancer and that 8,120 will die of this disease in 2011. The median age at which women are diagnosed with endometrial cancer is 63.
Laparoscopic hysterectomy said to offer better quality of life than abdominal procedure
International Federation of Gynecology and Obstetrics
Women's health research has shown a laparoscopic hysterectomy can leave females with a better quality of life four years on than an abdominal procedure. The study, which was published in journal Obstetrics & Gynaecology, involved questioning 59 random patients having the operation for benign indications. Of these, 27 were scheduled for a laparoscopic hysterectomy and 32 were having abdominal surgery.
Uterine fibroids common, but treatment has options
The discomfort crept up so gradually on Whitney Bauman of Urbana, Ill., she thought her symptoms were just part of getting older. After an ultrasound exam, Bauman learned the source of her discomfort was actually four fibroid tumors in her uterus — one the size of a softball and three more that were about walnut-size. The cause of uterine fibroid tumors, which are not cancerous, is unknown. Women of any age can get them, but they are most common among women in their 30s and 40s, according to the American Congress of Obstetricians and Gynecologists
Effects of allopregnanolone in women with severe pre-menstrual syndrome detailed
Umea University via News-Medical.net
Sensitivity to allopregnanolone, a hormone that occurs naturally in the body after ovulation and during pregnancy, changes during the course of the menstrual cycle and is different in women with severe pre-menstrual syndrome, compared with women without PMS complaints, according to a doctoral dissertation defended at Umea University, Sweden.
Faulty molecular switch can cause infertility or miscarriage
Scientists have discovered an enzyme that acts as a "fertility switch," in a study published in Nature Medicine. High levels of the protein are associated with infertility, while low levels make a woman more likely to have a miscarriage, the research has shown. The findings have implications for the treatment of infertility and recurrent miscarriage and could also lead to new contraceptives. Around one in six women have difficulty getting pregnant and one in 100 women trying to conceive have recurrent miscarriages, defined as the loss of three or more consecutive pregnancies.
Avastin disappoints against ovarian cancer
The Associated Press via USA Today
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their disease from worsening for only a few months, with more side effects.
Breast cancer patients face more imaging tests today
HealthDay via U.S. News & World Report
Women with breast cancer undergo many more imaging tests between diagnosis and surgery than they did in the early 1990s, a new study finds. The tests — breast ultrasounds, MRIs and mammograms — help doctors determine the best course of treatment, but add to the hassles and expense of care, the study says.
News from Reproductive Sciences
Postoperative adhesion development following cesarean and open intra-abdominal gynecological operations: A review
Reproductive Sciences, December 2011
In this review, the authors discuss the pathophysiology of adhesion development, the impact of physiological changes associated with pregnancy on markers of adhesion development, and the clinical implications of adhesion development following cesarean delivery. Although peritoneal adhesions develop after the overwhelming majority of intra-abdominal and pelvic surgery, there is evidence in the literature that suggests that patients having CD may develop adhesions less frequently. However, adhesions continue to be a concern after CD, and are likely significant, albeit on average less than after gynecological operations, but with potential to cause significant delay in the delivery of the baby with serious, lifelong consequences. More.
Hormone said to makes sex better and menopause manageable
Reuters via The Atlantic
A hormone called DHEA and mostly secreted by the adrenal glands may be able to help women who are going through menopause and could also give them better sex lives, a study found. Italian researchers writing in the journal of the International Menopause Society, Climacteric, said they had found the first robust evidence that low doses of DHEA can help sexual function and menopausal symptoms, suggesting it may one day become an alternative to hormone replacement therapy.
Do twin embryos help each other survive in IVF?
A new controversial study suggests a stronger embryo may help a weaker one survive in twin pregnancies created by in vitro fertilization. Spanish researchers found that the overall rate of survival to birth per embryo was 83 percent in twin pregnancies compared with 76 percent when women carried only one child. In a statistical analysis, the number of double births in twin pregnancies was higher than the researchers would have expected if the embryos didn't somehow help each other. By contrast, the number of single births was much lower than they expected.